Becton Dickinson Q3 FY26: where the revenue came from and where it went
The whole income statement of Becton Dickinson for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Apr 1 – Jun 30, 2026
- Reported
- Aug 6, 2026
Revenue$4.98B
−10% year over year
Gross profit$2.32B
46% margin
Operating profit$0.66B
13% margin
Net profit$0.38B
8% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 4.98 | 100% | −10% |
| Medical essentials | 1.65 | 33% | |
| Interventional | 1.36 | 27% | |
| Connected care | 1.12 | 23% | |
| BioPharma systems | 0.59 | 12% | |
| Other revenue | 0.27 | 5% | |
| Cost of revenue | −2.67 | 54% | |
| Gross profit | 2.32 | 46% margin | −1pp |
| R&D | −0.26 | 5% | +0pp |
| SG&A | −1.26 | 25% | +1pp |
| Other | −0.13 | 3% | +0pp |
| Operating profit | 0.66 | 13% margin | −2pp |
| Interest & other costs | −0.18 | ||
| Tax | −0.10 | ||
| Net profit | 0.38 | 8% margin |
76 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest